Published in Chin Med on June 12, 2009
Health effects of energy drinks on children, adolescents, and young adults. Pediatrics (2011) 3.52
Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci (2010) 1.78
Ginseng in traditional herbal prescriptions. J Ginseng Res (2012) 1.23
Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med (2010) 1.15
Phytotherapy in diabetes: Review on potential mechanistic perspectives. World J Diabetes (2014) 1.14
Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study. Medicine (Baltimore) (2016) 0.86
Effects of a multi-herbal extract on type 2 diabetes. Chin Med (2011) 0.83
Ethanol extract of mango (Mangifera indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats. J Food Sci Technol (2015) 0.80
Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility. PLoS One (2015) 0.79
Platyconic acid, a saponin from Platycodi radix, improves glucose homeostasis by enhancing insulin sensitivity in vitro and in vivo. Eur J Nutr (2011) 0.79
Fructus mume formula in the treatment of type 2 diabetes mellitus: a randomized controlled pilot trial. Evid Based Complement Alternat Med (2013) 0.79
Alternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic Inflammation. Rev Diabet Stud (2015) 0.77
Antihyperlipidemic effect of a polyherbal mixture in streptozotocin-induced diabetic rats. J Lipids (2013) 0.77
Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus. J Diabetes Investig (2015) 0.77
Pharmacological and phytochemical appraisal of selected medicinal plants from jordan with claimed antidiabetic activities. Sci Pharm (2013) 0.75
Antioxidant, antidiarrheal, hypoglycemic and thrombolytic activities of organic and aqueous extracts of Hopea odorata leaves and in silico PASS prediction of its isolated compounds. BMC Complement Altern Med (2016) 0.75
Evaluation of Phenolic Content Variability along with Antioxidant, Antimicrobial, and Cytotoxic Potential of Selected Traditional Medicinal Plants from India. Front Plant Sci (2016) 0.75
Assessment of Pharmacodynamic and Pharmacokinetic Interaction of Aqueous Extract of Cassia auriculata L. and Metformin in Rats. Pharmacogn Mag (2015) 0.75
Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med (1998) 4.50
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes (2006) 4.14
Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr (2004) 3.11
Panax ginseng. Am Fam Physician (2003) 2.71
American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med (2000) 2.67
Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr (2002) 2.52
Therapeutic applications of fenugreek. Altern Med Rev (2003) 2.12
Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism (2008) 2.09
Traditional chinese medicine in treatment of metabolic syndrome. Endocr Metab Immune Disord Drug Targets (2008) 1.94
Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm (2003) 1.70
Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med (2002) 1.69
Medication-induced mitochondrial damage and disease. Mol Nutr Food Res (2008) 1.68
The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol (1999) 1.65
Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis (2006) 1.56
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol (2008) 1.45
Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol (2006) 1.41
Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism (2007) 1.40
Alternative therapies for type 2 diabetes. Altern Med Rev (2002) 1.39
Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med (2007) 1.36
Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus. Curr Drug Discov Technol (2007) 1.32
A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res (2008) 1.29
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism (2009) 1.26
Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food (2005) 1.25
Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother Res (2009) 1.19
Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res (2001) 1.18
Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull (2008) 1.15
Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr (2006) 1.12
Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia. Nutr Rev (2006) 1.11
Alpha-glucosidase inhibition from a Chinese medical herb (Ramulus mori) in normal and diabetic rats and mice. Phytomedicine (2002) 1.10
Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care (2007) 1.10
American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. J Food Sci (2007) 1.10
Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J (Engl) (2008) 1.08
Korean red ginseng stimulates insulin release from isolated rat pancreatic islets. J Ethnopharmacol (2008) 1.07
Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull (Tokyo) (2006) 1.07
Anti-hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine (2003) 1.07
Recent methodology in the phytochemical analysis of ginseng. Phytochem Anal (2008) 1.06
Hypoglycaemic effect of Clausena anisata (Willd) Hook methanolic root extract in rats. J Ethnopharmacol (2002) 1.06
Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr (2003) 1.04
Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother Res (2001) 1.03
Glucose lowering effect of aqueous extract of Enicostemma littorale Blume in diabetes: a possible mechanism of action. J Ethnopharmacol (2002) 1.02
Use of complementary and alternative medicine in children with type 1 diabetes mellitus - prevalence, patterns of use, and costs. Pediatr Diabetes (2008) 1.01
Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J Biomed Sci (2003) 1.01
Effect of feeding aqueous extract of Pterocarpus marsupium on glycogen content of tissues and the key enzymes of carbohydrate metabolism. Mol Cell Biochem (2002) 1.01
The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res (1986) 1.01
Chromium and polyphenols from cinnamon improve insulin sensitivity. Proc Nutr Soc (2008) 1.00
Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab Res Rev (2008) 0.97
The insulinotropic activity of a Nepalese medicinal plant Biophytum sensitivum: preliminary experimental study. J Ethnopharmacol (2001) 0.97
Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr Metab Immune Disord Drug Targets (2008) 0.96
Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats. Eur J Pharmacol (2008) 0.96
Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol (2004) 0.96
Morphological evidence for the antiatherogenic effect of scoparone in hyperlipidaemic diabetic rabbits. Cardiovasc Res (1994) 0.95
Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods Hum Nutr (2005) 0.95
Antidiabetic principles of natural medicines. II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins I and II and myrciaphenones A and B. Chem Pharm Bull (Tokyo) (1998) 0.95
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. J Biol Inorg Chem (2002) 0.94
Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes. Diabetes Metab Res Rev (2005) 0.93
Hypoglycaemic activity of Pterocarpus marsupium Roxb. Phytother Res (2006) 0.92
Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.). J Biomed Sci (2006) 0.92
Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine (2007) 0.92
Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem (2007) 0.91
Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin Exp Pharmacol Physiol (2006) 0.90
Berberine acutely inhibits insulin secretion from beta-cells through 3',5'-cyclic adenosine 5'-monophosphate signaling pathway. Endocrinology (2008) 0.90
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol (2008) 0.89
Gymnema sylvestre: A Memoir. J Clin Biochem Nutr (2007) 0.89
Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J Pharmacobiodyn (1982) 0.88
The antihyperglycaemic blend effect of traditional chinese medicine byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) mice. Phytother Res (1999) 0.88
The insulinotropic activity of Gymnema sylvestre, R. Br. An Indian medical herb used in controlling diabetes mellitus. Pharmacol Res Commun (1981) 0.88
Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems. Nat Prod Res (2008) 0.88
Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol (2006) 0.88
Protective effect of ginseng on cytokine-induced apoptosis in pancreatic beta-cells. J Agric Food Chem (2007) 0.87
Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas (2003) 0.85
Chinese medicine, Jiang-Tang-Ke-Li, improves insulin resistance by modulating muscle fiber composition and muscle tumor necrosis factor-alpha in fructose-fed rats. Hypertens Res (2003) 0.85
Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects. Diabetes Obes Metab (2007) 0.84
Mode of action of ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism (2003) 0.84
Supplementation of fenugreek leaves to diabetic rats. Effect on carbohydrate metabolic enzymes in diabetic liver and kidney. Phytother Res (2003) 0.84
Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats. Diabetes Obes Metab (2003) 0.84
Biochemical study on the effects of some Egyptian herbs in alloxan-induced diabetic rats. Toxicology (2002) 0.82
Novel weight-reducing activity of Galega officinalis in mice. J Pharm Pharmacol (1999) 0.82
Effects of vanadyl sulfate on kidney in experimental diabetes. Biol Trace Elem Res (2003) 0.82
Effect of Coccinia indica leaf extract on plasma antioxidants in streptozotocin- induced experimental diabetes in rats. Phytother Res (2003) 0.81
Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm Metab Res (2007) 0.81
Inhibition of cytokine-mediated nitric oxide synthase expression in rat insulinoma cells by scoparone. Biol Pharm Bull (2007) 0.80
Challenges in natural health product research: The importance of standardization. Proc West Pharmacol Soc (2007) 0.80
[Effects of Hovenia dulcis Thunb on blood sugar and hepatic glycogen in diabetic mice]. Zhong Yao Cai (2002) 0.80
Effects of extracts of lupine seed on blood glucose levels in glucose resistant mice: antihyperglycemic effects of Lupinus albus (white lupine, Egypt) and Lupinus caudatus (tailcup lupine, Mesa Verde National Park). J Herb Pharmacother (2006) 0.79
Clinical evaluation of the effect of daio (rhei rhizoma) on the progression of diabetic nephropathy with overt proteinuria. Am J Chin Med (2003) 0.79
Does bitter melon contain an activator of AMP-activated kinase? Med Hypotheses (2004) 0.79
American ginseng modulates pancreatic beta cell activities. Chin Med (2007) 0.79
Hypoglycemic constituents of Panax ginseng. Gen Pharmacol (1985) 0.79
An overview of incretin clinical trials. J Fam Pract (2008) 0.78
Antidiabetic effect of nitobegiku in KK-Ay diabetic mice. Am J Chin Med (2002) 0.77
Combined potentiating effect of byakko-ka-ninjin-to, its constituents, rhizomes of Anemarrhena asphodeloides, tomosaponin A-III, and calcium on pilocarpine-induced saliva secretion in streptozocin-diabetic mice. Biol Pharm Bull (1996) 0.76
Antioxidative activity of (-)-epigallocatechin-3-(3''-O-methyl)gallate isolated from fresh tea leaf and preliminary results on its biological activity. Biosci Biotechnol Biochem (2000) 0.76
Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice. J Biomater Appl (2007) 0.76
Inhibition of the progression of type 2 diabetes in the C57BL/6J mouse model by an anti-diabetes herbal formula. Phytother Res (2003) 0.76
Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. J Pharm Pharmacol (2008) 0.76
Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr (2004) 9.01
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients. Pancreas (2008) 2.24
NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas (2010) 1.90
Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64
Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr (2004) 1.46
Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas (2005) 1.27
Vitamin D and colon carcinogenesis. J Nutr (2004) 1.26
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci U S A (2007) 1.24
Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency. Pancreas (2006) 1.21
Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta (2011) 1.17
Expression analysis of the prostaglandin E2 production pathway in human pancreatic cancers. Pancreas (2008) 1.12
Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol (2011) 1.11
Early detection of sporadic pancreatic cancer: summative review. Pancreas (2015) 1.10
The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.08
1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res (2002) 1.08
Biochemical testing for neuroendocrine tumors. Pancreas (2009) 1.07
Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol (2008) 1.02
The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas (2013) 0.94
Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett (2004) 0.94
Anti-hyperglycemic activity of zinc plus cyclo (his-pro) in genetically diabetic Goto-Kakizaki and aged rats. Exp Biol Med (Maywood) (2003) 0.93
Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter (2005) 0.93
A metabolic hypothesis of cell growth and death in pancreatic cancer. Pancreas (2002) 0.92
Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior. Pancreas (2010) 0.92
Membrane proteomic analysis of pancreatic cancer cells. J Biomed Sci (2010) 0.92
Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances. J Nutr Biochem (2005) 0.90
Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75. Metabolomics (2011) 0.90
Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population. Front Physiol (2013) 0.87
Nutrient-gene interaction: tracer-based metabolomics. J Nutr (2005) 0.87
A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy. Pancreas (2010) 0.86
Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion. Endocrinology (2006) 0.86
Estrogen receptors in pancreatic tumors. Pancreas (2006) 0.86
Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways. Pancreas (2010) 0.84
Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochim Biophys Acta (2011) 0.83
Validation of neurokinin a assays in the United States and Europe. Pancreas (2011) 0.83
Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis. Dig Dis Sci (2003) 0.82
Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells. Pancreas (2012) 0.81
Maintaining euglycemia prevents insulin-induced Fos expression in brain autonomic regulatory circuits. Pancreas (2005) 0.81
White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases. Cancer Prev Res (Phila) (2010) 0.80
Pancreatic cancer prevention and the 2010 Dietary Guidelines for Americans. Pancreas (2011) 0.80
Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper. Pancreas (2015) 0.80
Ethanol diversely alters palmitate, stearate, and oleate metabolism in the liver and pancreas of rats using the deuterium oxide single tracer. Pancreas (2009) 0.80
Neuroendocrine tumors: a critical appraisal of management strategies. Pancreas (2010) 0.79
Altered glucose and insulin responses to brain medullary thyrotropin-releasing hormone (TRH)-induced autonomic activation in type 2 diabetic Goto-Kakizaki rats. Endocrinology (2005) 0.79
Review of the International Research Conference on Food, Nutrition, and Cancer, 2004. J Nutr (2004) 0.78
Pilot studies to demonstrate that intestinal mucosal afferent nerves are functionally linked to visceral adipose tissue. Dig Dis Sci (2007) 0.78
Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media. Pancreas (2010) 0.78
Activation of raphe pallidus neurons increases insulin through medullary thyrotropin-releasing hormone (TRH)-vagal pathways. Pancreas (2002) 0.78
The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. Pancreas (2015) 0.78
Antidiabetic actions of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki rats. Metabolism (2003) 0.77
Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase. J Pharm Biomed Anal (2013) 0.76
Role of brainstem thyrotropin-releasing hormone-triggered sympathetic overactivation in cardiovascular mortality in type 2 diabetic Goto-Kakizaki rats. Hypertens Res (2011) 0.76
Dietary guidelines vs beverage guidance system. Am J Clin Nutr (2006) 0.76
The global transcriptional response of isolated human islets of langerhans to glucagon-like Peptide-1 receptor agonist liraglutide. ISRN Endocrinol (2012) 0.75
The American Pancreatic Association/Hirshberg Foundation Symposium celebrating the 10th anniversary of the Seed Grant program. Pancreas (2014) 0.75
International symposium: mechanism of pancreatitis--between bedside and laboratory. Pancreas (2002) 0.75
Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer. Pancreas (2016) 0.75
Overexpression of p53 Improves Blood Glucose Control in an Insulin Resistant Diabetic Mouse Model. Pancreas (2016) 0.75
Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper. Pancreas (2016) 0.75
Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 6, 2015, San Diego, California. Pancreas (2016) 0.75
Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers. Pancreas (2017) 0.75
Pancreas is 25 years old!: the past, present, and future. Pancreas (2010) 0.75
Asian-Oceanic Pancreatic Association: conception to actuality. Pancreas (2005) 0.75
Pancreas enters its third decade. Pancreas (2006) 0.75
Congratulations on the 40th anniversaries of the American Pancreatic Association and Japan Pancreas Society. Pancreas (2009) 0.75
Minutes of the Business Meeting of the American Pancreatic Association, Friday, October 28, 2016, Boston, Massachusetts. Pancreas (2017) 0.75
American Pancreatic Association: the Vay Liang and Frisca Go Award for lifetime achievement. Pancreas (2012) 0.75
Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 7, 2014, Kohala Coast, Hawaii. Pancreas (2015) 0.75
American Pancreatic Association: 2013 Vay Liang and Frisca Go award for lifetime achievement and distinguished service award. Pancreas (2013) 0.75
Proceedings of the 1st International Conference for Cancer Metabolism and Therapy, October 14-17, 2016, Dalian, China. Pancreas (2017) 0.75
Minutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida. Pancreas (2013) 0.75
2nd international symposium: Frontiers in pancreatic research-from basics to clinic and exocrine glands, Japan-Korea. Pancreas (2003) 0.75